ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

EVAX Evaxion Biotech AS

3.99
0.04 (1.01%)
최종 업데이트: 22:30:06
15분 지연
기업명 주식 심볼 시장 주식 타입
Evaxion Biotech AS EVAX 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.04 1.01% 3.99 22:30:06
개장가 저가 고가 종가 전일 종가
3.99 3.79 3.99 3.95
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202421:00GLOBEEvaxion Announces Phase 2 Clinical Trial Update: First..
02/04/202420:00GLOBEEvaxion and Undisclosed Collaborator Announce Encouraging..
27/03/202420:30GLOBEEvaxion Announces Business Update and Full Year 2023..
19/03/202420:30GLOBEEvaxion Hosts R&D Day and Unveils the Broad Potential of Its..
29/02/202421:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/02/202421:30GLOBEEvaxion to Host R&D Day on March 19, 2024, Highlighting its..
20/02/202421:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/02/202421:30GLOBEEvaxion Announces Successful Completion of the Initial..
08/02/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/02/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/02/202422:30GLOBEEvaxion Regains Compliance with Nasdaq Minimum Bid Price..
06/02/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/02/202422:30GLOBEEvaxion Announces Closing of $15 Million Public Offering
05/02/202423:09EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/02/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
01/02/202423:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/02/202423:20GLOBEEvaxion Biotech Announces Pricing of $15 Million Public..
01/02/202407:10EDGAR2Form F-1/A - Registration statement for certain foreign..
31/01/202423:26EDGAR2Form F-1/A - Registration statement for certain foreign..
31/01/202405:16EDGAR2Form F-1/A - Registration statement for certain foreign..
27/01/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/01/202404:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/01/202422:30GLOBEEvaxion to Develop Tailored Novel Cancer Vaccines Based upon..
23/01/202406:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/01/202406:30GLOBEEvaxion Announces Completion of ADS Ratio Change
13/01/202407:17EDGAR2Form F-1 - Registration statement for certain foreign..
12/01/202423:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/01/202422:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202422:30GLOBEEvaxion Announces Plan to Implement ADS Ratio Change
22/12/202306:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202306:30GLOBEEvaxion Biotech Announces Closing of Private Placement
20/12/202306:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202306:15GLOBEEvaxion Announces Business Update and Third Quarter 2023..
19/12/202323:25GLOBEEvaxion Biotech Announces Private Placement Financing
19/12/202322:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202306:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202322:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202322:27GLOBEEvaxion to Unveil Potentially Groundbreaking AI-Immunology™..
17/11/202323:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202322:00GLOBEEvaxion Presents Proof-of-Principle for Its Unique AI Model..
07/11/202300:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202300:12GLOBEEvaxion Shares Latest EVX-01 Phase 2 Clinical Data in..
01/11/202300:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202300:14GLOBEEvaxion Announces Encouraging Initial Phase 2 Clinical Data..
26/10/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202321:30GLOBENew and Exciting Clinical Data on Evaxion’s..
14/10/202305:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

Delayed Upgrade Clock